AbbVie Corporation

Jul 1, 2008

AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries.

À propos d’AbbVie
AbbVie est une société d’envergure mondiale centrée sur la recherche biopharmaceutique créée en 2013 à la suite de la scission des Laboratoires Abbott. La société a pour mission de mettre à profit son expertise, son personnel dévoué et son approche unique de l’innovation au développement et à la commercialisation de traitements évolués qui répondent à certaines des maladies les plus complexes et les plus graves au monde. AbbVie, y compris sa filiale à part entière, Pharmacyclics, emploie plus de 28 000 personnes et commercialise ses produits dans plus de 170 pays.

Alberta Health Services – Research

Apr 4, 2008

Alberta Health Services (AHS) is Canada’s first and largest province-wide, fully-integrated health system, responsible for delivering health services to the over four million people living in Alberta, as well as to some residents of Saskatchewan, B.C. and the Northwest Territories. AHS programs and services are offered at over 650 facilities throughout the province, including hospitals, clinics, continuing care facilities, cancer centres, mental health facilities and community health sites.   The province also has an extensive network of community-based services designed to assist Albertans maintain and/or improve health status.

As Alberta’s largest provider of care, AHS partners with Alberta’s universities, funders and others to enable frontline teams to test ideas and adopt them. By integrating research and innovation into the delivery of care, AHS can nurture health research breakthroughs, innovations and new knowledge to the point where they generate tangible, real world clinical value.

Alberta Innovates

Mar 23, 2008

Alberta Innovates is building on Alberta’s strengths in health, environment, energy, food, fibre and emerging technologies and is partnering with organizations to improve health and clinical research across the province. Managed by Alberta Innovates, the Alberta Clinical Research Consortium (ACRC) initiative aims to build capacity, increase efficiency and streamline the set-up and conduct of clinical health research in Alberta.

Amgen Canada

Feb 23, 2008

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit www.amgen.ca and follow us on www.twitter.com/amgen.